We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ajinomoto Bio-Pharma Services has completed the acquisition of Granules OmniChem Private Limited, purchasing the remaining 50 percent ownership interest from its joint venture partner, Granules India Limited.
Granules India has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility at Visakhapatnam, Andhra Pradesh.